Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06545435 · ClinicalTrials.gov registry record
Predicting Appendicular Lean and Fat Mass With Bioelectrical Impedance Analysis Among Adult Patients With Obesity.
A clinical trial of Obesity, sponsored by University of Roma La Sapienza.
- Recruiting
- Registry status
- 400
- Enrollment target
- 9
- Study locations
NCT06545435: Recruiting study of Obesity, sponsored by University of Roma La Sapienza.
NCT06545435 is a study of Obesity that is actively recruiting participants, run by University of Roma La Sapienza. The registered enrollment target is 400 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (51% lower). The trial reports 9 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06545435, a study of Obesity, is actively recruiting participants, sponsored by University of Roma La Sapienza.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 9
- Study locations
Study Summary
This study aims to develop and cross-validate novel bioelectrical impedance analysis (BIA) equations for predicting appendicular soft tissue masses, specifically fat mass (FM) and appendicular lean mass (ALM), in a sample of Caucasian adult subjects affected by obesity. The research will compare these new BIA equations with three established BIA-derived prediction models and validate them using dual-energy X-ray absorptiometry (DXA) and magnetic resonance imaging (MRI) data. This study utilizes existing datasets to enhance the accuracy and applicability of BIA in assessing body composition and supports the development of standardized algorithms for converting raw BIA data across different devices and populations.
Conditions Studied
Study Locations (9)
Other
- Curtin University, School of Population Health - Perth
- University of Cagliari, Department of Life and Environmental Sciences - Cagliari
- Sapienza, University of Rome - Roma
- Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy - Trieste
- Universidade de Lisboa, Exercise and Health Laboratory, CIPER, Faculdade de Motricidade Humana - Lisbon
Louisiana
- Pennington Biomedical Research Center, Louisiana State University - Baton Rouge
North Carolina
- Division of Geriatric Medicine, School of Medicine, and Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill - Chapel Hill
Rio Grande do Sul
- Federal University of Pelotas - Pelotas
Alberta
- University of Alberta, Department of Agricultural, Food and Nutritional Science - Edmonton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2021-05-13 |
| Est. Completion | 2025-12-31 |
What NCT06545435 shows while recruiting
NCT06545435 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (51% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT06545435 lists 9 locations in 5 states (Other, Louisiana, North Carolina).
Frequently Asked Questions
What is clinical trial NCT06545435 about?
NCT06545435 is a clinical study titled "Predicting Appendicular Lean and Fat Mass With Bioelectrical Impedance Analysis Among Adult Patients With Obesity.". This study aims to develop and cross-validate novel bioelectrical impedance analysis (BIA) equations for predicting appendicular soft tissue masses, specifically fat mass (FM) and appendicular lean mass (ALM), in a sample of Caucasian adult subjects affected by obesity. The research will compare the...
What is the current status of trial NCT06545435?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2021-05-13. Estimated completion is 2025-12-31.
What conditions does trial NCT06545435 study?
This clinical trial studies the following conditions: Obesity.
Who is sponsoring clinical trial NCT06545435?
This trial is sponsored by University of Roma La Sapienza, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06545435 being conducted?
This trial has 9 study locations across Louisiana, North Carolina, Rio Grande do Sul, Alberta. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06545435's enrollment target sits among peer trials
400 170th of 1053 higher than 881 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI